ASX Announcements
Market Sensitive
2024 AGM Chairman's Address and CEO Presentation
Company Presentation, Chairman's Address to Shareholders
- Nov 20, 2024
- 14 pages
Market Sensitive
Quarterly Activities/Appendix 4C Cash Flow Report
CTE – First Quarter Cashflow Report, CTE - First Quarter Activity Report
- Oct 31, 2024
- 9 pages
Notice of Annual General Meeting/Proxy Form
Notice of Annual General Meeting, Proxy Form, Letter to Shareholders
- Oct 18, 2024
- 25 pages
June
Chris Abbott-backed Genetic Signatures raises $30 million
There’s an FDA approval in the bag, and a CEO replacement for long-standing boss John Melki has been found. And of course, the stock is up 78 per cent year to date.
- Sarah Thompson, Kanika Sood and Emma Rapaport
October 2020
ASX tumbles 1.4pc after Trump COVID shock; Worst week since April
The sharemarket fell 1.4 per cent on Friday after US President Donald Trump confirmed he tested positive for COVID-19. ASX drops 2.9 per cent for the week, the worst weekly performance since late April.
- Updated
- Robert Guy, Vesna Poljak, Sarah Turner, William McInnes and Tom Richardson
April 2020
Genetic Signatures up 12pc on COVID-19 test approval
ASX-listed company Genetic Signatures' testing kit for the virus causing COVID-19 received European approval on Wednesday.
- Yolanda Redrup
October 2019
Bell Potter on healthcare raising blitz
Bell Potter has kicked off two raisings for companies in the healthcare sector.
- Sarah Thompson, Anthony Macdonald and Tim Boyd